Nippon Shinyaku Co., Ltd. (TYO:4516)

Japan flag Japan · Delayed Price · Currency is JPY
4,904.00
+69.00 (1.43%)
At close: Mar 5, 2026
Market Cap325.88B +24.0%
Revenue (ttm)166.05B +5.9%
Net Income29.85B -1.8%
EPS442.94 -1.9%
Shares Out67.40M
PE Ratio10.92
Forward PE11.94
Dividend124.00 (2.48%)
Ex-Dividend DateMar 30, 2026
Volume229,400
Average Volume300,415
Open4,905.00
Previous Close4,835.00
Day's Range4,887.00 - 4,965.00
52-Week Range2,967.00 - 6,529.00
Beta-0.33
RSI40.34
Earnings DateFeb 9, 2026

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leb... [Read more]

Sector Healthcare
Founded 1911
Employees 2,243
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4516
Full Company Profile

Financial Performance

In fiscal year 2025, Nippon Shinyaku's revenue was 160.23 billion, an increase of 8.08% compared to the previous year's 148.26 billion. Earnings were 32.56 billion, an increase of 25.94%.

Financial Statements